Dr. Starr was previously director of the cardiac surgery program at Children’s Hospital of New Jersey and an associate professor at the New Jersey Medical School at the University of Medicine and Dentistry of New Jersey, in Newark. She is a member of numerous societies and a founding member of the World Society for Pediatric and Congenital Heart Surgery. She has served as lead and associate surgeon on several international congenital heart surgery missions, including to the Dominican Republic, Ecuador and Uganda.
Dr. Starr’s research interests in hybrid congenital heart surgery and myocardial protection complement the innovative and pioneering nature of the Heart Institute at CHOC – the only regional facility performing neonatal and pediatric open heart surgery. Dr. Starr has co-authored more than 50 abstracts and manuscripts that have been presented at national and international conferences. Several have focused on hybrid cardiac surgery, collaborative procedures involving interventional cardiologists and cardiac surgeons.
Dr. Starr has served as co-investigator on multi-center studies, including evaluating Esmolol for treating hypertension after surgical repair of coarctation of the aorta; REPEL-CV for reducing post-operative adhesions following pediatric cardiothoracic surgery; and Clopidogrel to lower arterial thrombotic risk in neonates and infants. Most recently, she was co-investigator for an American Heart Association grant, Human Factors and Patient Safety During Infant Cardiac Surgery.
CHOC Children’s Specialists Cardiothoracic Surgery
505 W. La Veta, Suite 200
Orange, CA 92868
Medical Director, Cardiothoracic Surgery, CHOC Children’s
Jacoby K, Starr JP, Gates RN, Domico M, Quill, A. Clinical guideline for the assessment of vocal cord dysfunction post cardiac surgery in neonates. PCICS. 2014; Abstract Poster.
Herrera M, Starr JP, Morchi G, Phillips K, Palafox B, Domico M. Development of clinical practice guidelines for postoperative chylothorax in pediatric cardiac surgical patients. PCICS. 2014; Abstract Poster.
Peterson J, Starr JP, Gates RN, Evangelista L. Is neonatal hearing dysfunction associated with developmental delay following cardiac surgery. Fourth Annual Cardiac Neurodevelopmental Symposium. 2015; Abstract Poster.
Starr JP, Domico M, Nugent D, Gates RN, Palafox BA, Ramirez R, Quill, A. Use of human plasma derived antithrombin vs. recombinant antithrombin in pediatric ECMO: a retrospective cohort study. ELSO Meeting. 2015; Abstract Poster.
Nossair F, Mahajerin A, Starr J, Kirov I. Superior Vena Cava Syndrome: an evidence-based analysis of reported cases in the English-language literature from 1990-2015. 29th Annual Meeting American Society of Pediatric Hematology/Oncology. 2016; Abstract Poster.
Mohari N, Starr JP, Gates RN, Domico MB, Batra AS. Bipolar versus unipolar temporary epicardial ventricular pacing leads use in congenital heart disease: A prospective randomized controlled study. Pacing Clin Electrophysiol. 2016; 39(5):471-7.
Starr JP, Gates RN, Palafox BA, Quill A. Retrospective Cohort Study Comparing Redo Operations Using Ferromagnetic Dissection and Conventional Monopolar Dissection. Surg Innov. 2016; Epub ahead of print.
Nguyen AK, Palafox BA, Starr JP, Gates RN, Berdjis F. Endocarditis and Incomplete Endothelialization 12 years after Amplatzer Septal Occluder Deployment. Tex Heart Inst J. 2016; 43(3):227-31.
Dr. Joanne Starr, pediatric cardiothoracic surgeon, discusses the signs, treatment and long-term outcome of children born with Tetralogy of Fallot.
Dr. Joanne Starr, pediatric cardiothoracic surgeon, explains what to expect when a child is on extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS).
In the newborn population, there are many heart conditions that may need surgery. Many of these heart surgeries are new at least in the past 10 to 20 years.